Oral malodorous compound induces osteoclast differentiation without receptor activator of nuclear factor κb ligand

Journal of Periodontology

Volumn 81, Issue 11, 2010, Pages 1691-1697

  Ii, Hisataka ^a   Imai, Toshio ^a   Yaegaki, Ken ^a   Irie, Koichiro ^b   Ekuni, Daisuke ^b   Morita, Manabu ^b  

^a NIPPON DENTAL UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cell differentiation; Halitosis; Hydrogen sulfide; Mitogenactivated protein kinases; Osteoclasts

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM PHOSPHATE; CATHEPSIN K; CTSK PROTEIN, MOUSE; ENZYME INHIBITOR; FLAVONOID; HYDROGEN SULFIDE; IMIDAZOLE DERIVATIVE; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; PYRIDINE DERIVATIVE; TARTRATE-RESISTANT ACID PHOSPHATASE; TNFSF11 PROTEIN, MOUSE;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; HALITOSIS; MACROPHAGE; METABOLISM; MOUSE; OSTEOCLAST; PHOSPHORYLATION; WESTERN BLOTTING;

ACID PHOSPHATASE; ANIMALS; BLOTTING, WESTERN; CALCIUM PHOSPHATES; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CATHEPSIN K; CELL DIFFERENTIATION; CELL LINE; ENZYME INHIBITORS; FLAVONOIDS; HALITOSIS; HYDROGEN SULFIDE; IMIDAZOLES; ISOENZYMES; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OSTEOCLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; RANK LIGAND;

EID: 78249231388     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2010.100116     Document Type: Article

References (37)

1. Yaegaki K, Sanada K. Volatile sulfur compounds in mouth air from clinically healthy subjects and patients with periodontal disease. J Periodontal Res 1992;27:233-238.
2. Yaegaki K, Coil JM. Examination, classification, and treatment of halitosis: Clinical perspectives. J Can Dent Assoc 2000;66:257-261.
3. Persson S. Hydrogen sulfide and methyl mercaptan in periodontal pockets. Oral Microbiol Immunol 1992;7:378-379.
4. Rizzo AA. The possible role of hydrogen sulfide in human periodontal disease. I. Hydrogen sulfide production in periodontal pockets. Periodontics 1967;5:233-236.
5. Johnson PW, Yaegaki K, Tonzetich J. Effect of volatile thiol compounds on protein metabolism by human gingival fibroblasts. J Periodontal Res 1992;27:553-561.
6. Johnson P, Yaegaki K, Tonzetich J. Effect of methyl mercaptan on synthesis and degradation of collagen. J Periodontal Res 1996;31:323-329.
7. Setoguchi T, Machigashira M, Yamamoto M, et al. The effects of methyl mercaptan on epithelial cell growth and proliferation. Int Dent J 2002;52(Suppl. 3):241-246.
8. Takeuchi H, Setoguchi T, Machigashira M, Kanbara K, Izumi Y. Hydrogen sulfide inhibits cell proliferation and induces cell cycle arrest via an elevated p21 Cip1 level in Ca9-22 cells. J Periodontal Res 2008;43:90-95.
9. Yaegaki K, Qian W, Murata T, et al. Oral malodorous compound causes apoptosis and genomic DNA damage in human gingival fibroblasts. J Periodontal Res 2008;43:391-399.
10. Calenic B, Yaegaki K, Murata T, et al. Oral malodorous compound triggers mitochondrial-dependent apoptosis and causes genomic DNA damage in human gingival epithelial cells. J Periodontal Res 2010;45:31-37.
11. Ng W, Tonzetich J. Effect of hydrogen sulfide and methyl mercaptan on the permeability of oral mucosa. J Dent Res 1984;63:994-997.
12. Tonzetich J. Effect of volatile sulphur compounds on periodontal tissues and cellular metabolism: An overview. In: van Steenberghe SD, Rosenberg M, eds. Bad Breath, A Multidisciplinary Approach. Leuven, Belgium: Leuven University Press; 1996:79-91.
13. Ratkay LG, Tonzetich J, Waterfield JD. Antibodies to extracellular matrix proteins in the sera of MRL-lpr mice. Clin Immunol Immunopathol 1991;59:236-245.
14. Yaegaki K. Oral malodorous compounds are periodontally pathogenic and carcinogenic. Jpn Dent Sci Rev 2008;44:100-108.
15. Fujimura M, Calenic B, Yaegaki K, et al. Oral malodorous compound activates mitochondrial pathway inducing apoptosis in human gingival fibrobrasts. Clin Oral Investig 2010;14:367-373.
16. Squier CA, Johnson NW. Permeability of oral mucosa. Br Med Bull 1975;31:169-175.
17. Ratkay LG, Waterfield JD, Tonzetich J. Stimulation of enzyme and cytokine production by methyl mercaptan in human gingival fibroblast and monocyte cell cultures. Arch Oral Biol 1995;40:337-344.
18. Imai T, Ii H, Yaegaki K. et al. Oral malodorous compound inhibits osteoblast proliferation. J Periodontol 2009;80:2028-2034.
19. Irie K, Ekuni D, Yamamoto T, et al. A single application of hydrogen sulphide induces a transient osteoclast differentiation with RANKL expression in the rat model. Arch Oral Biol 2009;54:723-729.
20. Ralph P, Nakoinz I. Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: Enhancement by PPD and LPS. J Immunol 1977;119:950-954.
21. Sugatani T, Alvarez U, Hruska KA. PTEN regulates RANKL-and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility. J Biol Chem 2003;278:5001-5008.
22. Available at: http://rsbweb.nih.gov/ij/. Accessed September 10, 2009.
23. Persson S, Edlund MB, Claesson R, Carlsson J. The formation of hydrogen sulfide and methyl mercaptan by oral bacteria. Oral Microbiol Immunol 1990;5:195-201.
24. Solis-Gaffar MC, Rustogi KN, Gaffar A. Hydrogen sulfide production from gingival crevicular fluid. J Periodontol 1980;51:603-606.
25. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999;20:345-357. (Pubitemid 30649812)
26. Yoshida H, Hayashi S, Kunisada T, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990;345:442-444. (Pubitemid 120014957)
27. Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A. Tumor necrosis factor-a induces differentiation of and bone resorption by osteoclasts. J Biol Chem 2000;275:4858-4864.
28. Lader CS, Flanagan AM. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro. Endocrinology 1998;139:3157-3164.
29. Nason R, Jung JY, Chole RA. Lipopolysaccharideinduced osteoclastogenesis from mononuclear precursors: A mechanism for osteolysis in chronic otitis. J Assoc Res Otolaryngol 2009;10:151-160.
30. Ikawa Y, Yonekawa T, Ohkuni Y, Kuribayashi M, Fukino K, Ueno K. A comparative study of histamine activities on differentiation of osteoblasts and osteoclasts. J Toxicol Sci 2007;32:555-564.
31. Yen ML, Tsai HF, Wu YY, Hwa HL, Lee BH, Hsu PN. TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells. Mol Immunol 2008;45:2205-2213.
32. Takayanagi H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med 2005;83:170-179.
33. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337-342.
34. Li X, Udagawa N, Itoh K, et al. p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 2002;143:3105-3113.
35. Kyriakis JM, Banerjee P, Nikolakaki E, et al. The stress-activated protein kinase subfamily of c-Jun. kinases. Nature 1994;369:156-160.
36. Raingeaud J, Gupta S, Rogers JS, et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995;270:7420-7426.
37. Miyazaki H, Sakao S, Katoh Y, Takehara T. Correlation between volatile sulphur compounds and certain oral health measurements in the general population. J Periodontol 1995;66:679-684.